Aratana Therapeutics Inc (NASDAQ:PETX)

Data as of Oct 17
 -0.43 / -3.79%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Generic

Company Description

Aratana Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics. It delivers innovative prescription medicines that address significant medical needs for cats and dogs (companion animals). The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. Aratana Therapeutics was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Kansas City, KS.

Contact Information

Aratana Therapeutics, Inc.
1901 Olathe Boulevard
Kansas City Kansas 66103
P:(913) 951-2132
Investor Relations:



Other institutional33.81%
Mutual fund holders33.72%
Individual stakeholders27.34%

Top Executives

Steven St. PeterPresident, Chief Executive Officer & Director
Craig A. ToomanChief Financial Officer
Linda RhodesDirector & Chief Scientific Officer
Erwin BlomsmaVice President
Michele A. GallucciVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.